John Dinka

John Dinka is an experienced professional in drug product process engineering and manufacturing operations, currently serving as the Director of Drug Product Process Engineering and Facility Design at Novavax since 2020. Dinka has a robust background in overseeing technology transfers for vaccine programs and developing operational readiness plans. Prior roles include serving on the Scientific Advisory Board at the Jefferson Institute for Bioprocessing and as a Principal Consultant at CAI. Dinka held various senior director positions at West Pharmaceutical Services, focusing on R&D and manufacturing innovation, and led critical initiatives during tenures at Eli Lilly and Company and DURECT Corporation. Dinka began a career in the pharmaceutical industry as a Senior Consultant and Associate Director at VIVUS LLC, developing expertise in facility design and product lifecycle management. Dinka holds a Bachelor of Science in Business Administration from Delaware Valley University.